Innovus Pharma, a San Diego-based marketer of dietary supplements and OTC products, has in recent weeks secured $3 million in additional funding, purchased an online sales platform as well as announced a pilot trial on a muscle health supplement.
Chinese/American company Lyxia has debuted as a new player in the algae omega-3s space with a highly refined EPA ingredient from a photosynthetic strain.
The European Medicines Agency (EMA) has said omega-3 fatty acid medicines are not effective in preventing further heart and blood vessels problems after heart attack – meaning medicines containing DHA and EPA for this purpose will no longer be authorised...
How can you create excitement in a mature and established category like omega-3? We chat with Andrew Aussie, COO of Coromega, who brought in marketing expertise from across categories to help an omega-3 brand evolve into a healthy fats brand.
Assessment of nutritional status and solutions to micronutrient deficiencies must be in sync if maternal and infant health is to improve, says Peter van Dael, DSM's Senior VP of Nutrition Science and Advocacy.
The importance of adequate nutrition and targeted supplementation for war fighters is a rapidly evolving field, according to an expert who has counseled sailors on the subject.
Despite the equivocal reports in the mainstream media of the recently released omega-3s trials, the huge statistical power of the studies means the promising secondary endpoints can be trusted, experts say.
Dietary supplements have held out the promise of greater health. Has the category delivered on that promise? Are people healthier now than they were decades ago?
Krill-derived omega-3 fatty acids appear to reduce fasting levels of blood glucose, a Rimfrost-funded study finds, as researchers point to its supplementation as an effective approach in reducing cardiovascular disease (CVD) risk.
Amarin Corporation, maker of EPA drug Vascepa, has sued two omega-3s finished good manufacturers for unfair trade practices for allegedly using the results of the company’s large scale drug trial to market their own fish-oil based dietary supplements.
GOED has clarified what method should be used by member companies to calculate the EPA and DHA content of their products to avoid confusion for consumers.
You’ve heard of EPA and DHA omega-3, but what about ETA? A new study from Canada indicates that ETA (eicosatetraenoic acid, 20:4) may convert into two novel compounds associated with inflammation management.
A population study conducted on a cohort living in Boston has found an association of higher blood levels of omega-3s with better executive function in older individuals. The researchers also found negative connotations with higher omega-6 levels.
Researchers in Australia found that pre-menopausal women supplemented with 1 g of DHA-rich tuna oil had significantly lowered triglyceride levels compared to those who took the placebo.
A review conducted by researchers in New York uncovered six potential modes of action for how omega-3s might alleviate symptoms of anxiety. But the researchers found lots of nits to pick with the research, too, and made recommendations for future studies...
French microalgae firm Fermentalg and Madrid-based fermentation specialist ADL BioPharma have signed a long-term manufacturing contract for the production of algal omega-3 oils.
Results from an omega-3 study found a positive link between treatment using EPA and cardiovascular outcomes. It was backed by pharmaceutical company Amarin, which enjoyed a 300% surge in shares after the study results were announced.
Omega-3s are a category of products that embody the notion that supplements are getting ‘better.’ They started out at a high level and have gone on from there.
Prostate health is an often neglected area of men’s health, one that could drive significant growth in the future sales of herbal supplements as questions of healthy aging come to the fore, a prominent industry executive says.
Algae products manufacturer iWi has landed a deal with Sam’s Club that will greatly expand distribution of the company’s signature products based on omega-3s bound to polar lipids produced by a proprietary algal strain.
Supplementation with a marine oil lipid extract derived from New Zealand green-lipped mussels does not benefit resting pulmonary or muscle function in non-asthmatic elite runners, according to a recent population study.
Results from a long term trial in diabetes patients showed that omega-3s did not prevent heart attacks or strokes. Experts within the industry raised questions about how the results were reported, the baseline levels of the study population as well as...
Aker BioMarine has entered into a partnership with the Lupus Research Alliance that will potentially help sufferers of the disorder, as well as help Aker better understand the mechanisms of action of krill oil.
The ongoing patent struggle in the krill oil sphere has taken another turn with a victory for Rimfrost in its contest with fellow Norwegian competitor Aker BioMarine.
Supplementation with omega-3 fatty acids is linked to more pre-operative weight loss and better post-operative outcomes in gastric bypass patients, according to a new clinical trial.
A recent pilot study has linked a higher Omega 3 Index with lessened symptoms of depression in a cohort of subjects suffering from chronic heart failure.
The growth of the omega-3s sector has slowed in recent years, partly due to consumers growing tired of the typical fish oil gel capsule, which is why companies such as CoreFX Specialty Ingredients are developing a host of plant-based fatty acid solutions...
A recent study conducted by researchers in the UK concluded that an emulsified cod liver oil boosted the uptake of EPA and DHA. Experts are divided about how the results might affect the marketplace.
Utah-based network marketing company LifeVantage has reported year end earnings gains and sales increases in all its markets as it starts to fully enter the biggest market of all—Mainland China.
Orivo has scored its first win in the US market with the announcement by practitioner channel supplements specialist Biotics Research Corporation that it will use the Norwegian company’s authenticity certification on its fish oil products.
Eating more long-chain omega-3 fatty acids (LC-PUFAs) could help control non-alcoholic fatty liver disease (NAFLD), according to a meta-analysis of existing data.
Females and younger adults in the UK appear to be vulnerable to micronutrient shortfalls, a concern given this life period includes the conception and childbearing years, the survey’s author warns.
Pregnant women with low plasma levels of long chain omega-3 fatty acids in their first and second trimesters may be at a significantly higher risk of early preterm birth, new research suggests.
Young children with the highest levels of omega-3s in their blood outperformed their peers on a measure of executive function, according to new research conducted in West Africa.
Preventative and personalised nutrition brings enormous opportunity but only addresses health needs of a small population segment, warns the president of human nutrition and health at DSM.
Reaction continues to roll in on the recent Cochrane review that found little evidence supporting the cardiovascular benefits of omega-3s. Experts questioned the underlying assumptions in how the review was put together.
Australian omega-3 canola oil firm Nuseed has applied for regulatory approval for its product in the US and Canada, and has outlined plans for its expansion across APAC.
Special Edition: Transparency in Dietary Supplements
Securing sources of supply is not only good business practice, it can also boost a company’s transparency efforts. Examples abound of companies putting raw cost concerns aside to push forward efforts to make sure fragile ecosystems are protected and potentially...
A new review from Cochrane has come to the conclusion that there is not enough evidence to support the effects of omega-3s on forestalling heart disease, stroke or death.
Dietary ingredients have still mostly escaped the most recent iteration of tariff lists for Chinese goods released by the Trump Administration. The real risk is not to the bottom line but to trade relationships in general, experts in the industry agree.